SCHEMBL284801

SCHEMBL284801

Clc1cnc2c3ccccc3c3ccccc3c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
CYP3A4 P08684 2/20 0.37
CCR1 P32246 1/20 0.37
CCR8 P51685 1/20 0.37
APEX1 P27695 1/20 0.37
MAPK1 P28482 1/20 0.37
PMP22 Q01453 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
PTGES O14684 1/20 0.36
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29476068 1.00 ALDH1A1 (0.40) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL17782983 0.79 PTGER4 (0.46) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL17782976 0.78 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL29344299 0.77 ALDH1A1 (0.39) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL12328777 0.77
SCHEMBL14480595 0.75 PTGER4 (0.46) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL10063498 0.74 CYP2A6 (0.43) ALDH1A1L3MBTL1MAPTCCR1CCR8
SCHEMBL30779331 0.74 CYP2A6 (0.43) ALDH1A1L3MBTL1MAPTCCR1CCR8
SCHEMBL16225200 0.74 ALDH1A1 (0.37) ALDH1A1L3MBTL1LMNAMAPTCYP3A4
SCHEMBL16225048 0.74 ALDH1A1 (0.37) ALDH1A1L3MBTL1LMNAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695158-B2 Dibenzo[f,h]quinoxaline derivative, method of synthesizing the same, light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-07-04 US claimed
US-20150080574-A1 Dibenzo[f,h]Quinoxaline Derivative, Method of Synthesizing the Same, Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2015-03-19 US claimed
US-12581794-B2 Light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-03-17 US disclosed
US-20250126962-A1 Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-04-17 US disclosed
US-20250063937-A1 Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-02-20 US disclosed
US-20250042877-A1 ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-02-06 US disclosed
US-12150325-B2 Light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-11-19 US disclosed
US-12100795-B2 Light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-09-24 US disclosed
US-20240215287-A1 Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-27 US disclosed
US-20240215287-A1 Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-27 US disclosed
US-20240215287-A1 Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-06-27 US disclosed
EP-2363398-A1 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-09-07 EP disclosed
EP-2363398-A1 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-09-07 EP disclosed
US-20110210316-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-09-01 US disclosed
US-20110210316-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-09-01 US disclosed
US-20110210316-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-09-01 US disclosed
US-20090322217-A1 ORGANOMETALLIC COMPLEX, AND LIGHTING APPARATUS, AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-12-31 US disclosed
US-20090322217-A1 ORGANOMETALLIC COMPLEX, AND LIGHTING APPARATUS, AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-12-31 US disclosed
US-20090322217-A1 ORGANOMETALLIC COMPLEX, AND LIGHTING APPARATUS, AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-12-31 US disclosed
WO-2009157498-A1 ORGANOMETALLIC COMPLEX, AND LIGHTING APPARATUS, AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210316-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE NQO1, DDT, CYP1A1 ALDH1A1 145/4885L3MBTL1 833/4885LMNA 1533/4885
US-12100795-B2 Light-emitting element HPRT1, NR2E3, LAGE3 ALDH1A1 2287/4885L3MBTL1 508/4885LMNA 1864/4885
US-20250063937-A1 Light-Emitting Element HPRT1, APRT, LAGE3 ALDH1A1 1637/4885L3MBTL1 83/4885LMNA 2033/4885
US-20090322217-A1 ORGANOMETALLIC COMPLEX, AND LIGHTING APPARATUS, AND ELECTRONIC DEVICE USING THE ORGANOMETALLIC COMPLEX AP3M1, AP1M1, AP2M1 ALDH1A1 944/4885L3MBTL1 135/4885LMNA 2633/4885
US-12581794-B2 Light-emitting element CTNNB1, CRY1, TPMT ALDH1A1 911/4885L3MBTL1 1677/4885LMNA 967/4885
US-20250042877-A1 ORGANIC COMPOUND, ORGANIC DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC APPLIANCE OLA1, ODC1, H1-0 ALDH1A1 711/4885L3MBTL1 441/4885LMNA 4181/4885
US-20150080574-A1 Dibenzo[f,h]Quinoxaline Derivative, Method of Synthesizing the Same, Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device DDT, DHODH, INF2 ALDH1A1 1183/4885L3MBTL1 375/4885LMNA 2410/4885
US-20240215287-A1 Light-Emitting Element NR2E3, ERCC1, HPRT1 ALDH1A1 878/4885L3MBTL1 1157/4885LMNA 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.